In this video, Deepak Bhatt, MD, MPH, overviews the findings from the eicosapentaenoic acid (EPA) analysis of the REDUCE-IT trial and what impact the results may have on the future of cardiovascular...
In this video, Keith C. Ferdinand, MD, from Tulane University, discusses how community-based hypertension control programs can be successfully implemented into barbershops and other community centers.
Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...
In this video, James Matera, MD, talks about the critical questions patients have about CKD, the impact of CKD on comorbid conditions and the need to limit risk, and more.
James Matera, MD, talks about the association between cardiometabolic diseases and hyperkalemia, the benefits and risks of various treatment approaches for chronic hyperkalemia, and more.
Dr James Matera from CentraState Medical Center in Freehold, NJ, names the key takeaways from his session at CRS 2018, "Addressing Your Patient's Cardiometabolic Risk: Management of Complex Hypertension...
Dr James Matera from CentraState Medical Center in Freehold, NJ, gives us an overview of his session from the 2018 Cardiometabolic Risk Summit in San Antonio, TX.
Andrew Waxler, MD, FACC, discusses the Corus CAD test that can rule out CAD in patients presenting with possible symptoms, which would avoid unnecessary and costly procedures and guide physicians...
Calcium plaque is a known risk factor for heart attacks. In this video, Catherine Dolf discusses the results of a study that determined the predictive ability of calcium amount and density for determining a...
